Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Catalent Inc (CTLT)

Catalent Inc (CTLT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,408,674
  • Shares Outstanding, K 170,342
  • Annual Sales, $ 3,094 M
  • Annual Income, $ 173,000 K
  • 60-Month Beta 1.43
  • Price/Sales 5.34
  • Price/Cash Flow 31.84
  • Price/Book 5.34
Trade CTLT with:

Options Overview

Details
  • Implied Volatility 33.71%
  • Historical Volatility 21.81%
  • IV Percentile 20%
  • IV Rank 18.57%
  • IV High 72.03% on 10/28/20
  • IV Low 24.97% on 06/24/21
  • Put/Call Vol Ratio 0.04
  • Today's Volume 208
  • Volume Avg (30-Day) 214
  • Put/Call OI Ratio 2.21
  • Today's Open Interest 7,561
  • Open Int (30-Day) 7,835

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 1.01
  • Number of Estimates 4
  • High Estimate 1.05
  • Low Estimate 0.97
  • Prior Year 0.85
  • Growth Rate Est. (year over year) +18.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
108.12 +10.81%
on 07/01/21
121.11 -1.07%
on 07/30/21
+11.69 (+10.81%)
since 06/30/21
3-Month
98.73 +21.35%
on 05/19/21
121.11 -1.07%
on 07/30/21
+7.34 (+6.53%)
since 04/30/21
52-Week
79.65 +50.42%
on 09/25/20
127.68 -6.16%
on 02/16/21
+31.71 (+35.99%)
since 07/30/20

Most Recent Stories

More News
Exact Sciences (EXAS) Q2 Loss Wider Than Expected, Revenues Top

Exact Sciences' (EXAS) legacy Screening business sees significant improvement in revenues during the second quarter on Cologuard volume growth.

AMN : 100.56 (+0.58%)
GMED : 83.17 (-0.25%)
EXAS : 107.84 (-3.64%)
CTLT : 119.81 (+0.41%)
LabCorp (LH) Q2 Earnings Surpass Estimates, 2021 View Raised

LabCorp (LH) Diagnostics revenues in the second quarter increase significantly on organic Base Business volume improvements despite decelerating demand for COVID-19 testing.

LH : 296.15 (+0.51%)
AMN : 100.56 (+0.58%)
WST : 411.73 (+1.68%)
CTLT : 119.81 (+0.41%)
CONMED's (CNMD) Q2 Earnings Surpass Estimates, '21 View Up

CONMED (CNMD) witnesses revenue uptick in both of its segments during Q2 despite continued pandemic-led business disruptions.

CNMD : 137.94 (-0.08%)
AMN : 100.56 (+0.58%)
CTLT : 119.81 (+0.41%)
CHNG : 21.71 (-1.36%)
Baxter (BAX) Q2 Earnings Surpass Estimates, Revenues Miss

Baxter's (BAX) second-quarter results reflect robust performance across all its business units.

BAX : 77.35 (-0.04%)
AMN : 100.56 (+0.58%)
CTLT : 119.81 (+0.41%)
CHNG : 21.71 (-1.36%)
West Pharmaceutical (WST) Q2 Earnings & Revenues Top Estimates

West Pharmaceutical's (WST) second-quarter earnings reflect strong segmental performance.

AMN : 100.56 (+0.58%)
WST : 411.73 (+1.68%)
CTLT : 119.81 (+0.41%)
CHNG : 21.71 (-1.36%)
Hologic's (HOLX) Q3 Earnings Top Estimates, Q4 View Dull

Impressive performance by the Breast Health and GYN Surgical segments drive Hologic's (HOLX) fiscal third-quarter revenues.

HOLX : 75.04 (+1.65%)
AMN : 100.56 (+0.58%)
WST : 411.73 (+1.68%)
CTLT : 119.81 (+0.41%)
Align Technology (ALGN) Q2 Earnings Top Estimates, 2021 View Up

Strength in Invisalign Clear Aligners and iTero scanners sales volumes during the fiscal second quarter drove Align Technology's (ALGN) top line.

ALGN : 695.80 (+2.78%)
AMN : 100.56 (+0.58%)
WST : 411.73 (+1.68%)
CTLT : 119.81 (+0.41%)
Thermo Fisher (TMO) Beats on Q2 Earnings, Raises 2021 View

Thermo Fisher's (TMO) base business witnesses accelerated growth in the second quarter.

TMO : 540.01 (+1.17%)
AMN : 100.56 (+0.58%)
GMED : 83.17 (-0.25%)
CTLT : 119.81 (+0.41%)
Masimo's (MASI) Q2 Earnings Surpass Estimates, '21 View Up

Masimo's (MASI) robust product shipments, along with strong rebound in sensor sales, drive its Q2 sales.

MASI : 272.39 (-0.15%)
AMN : 100.56 (+0.58%)
WST : 411.73 (+1.68%)
CTLT : 119.81 (+0.41%)
Stryker (SYK) Q2 Earnings and Revenues Surpass Estimates

Stryker's (SYK) second-quarter earnings reflect strong performance across Orthopaedics, MedSurg and Neurotechnology and Spine segments.

SYK : 270.94 (+0.65%)
AMN : 100.56 (+0.58%)
WST : 411.73 (+1.68%)
CTLT : 119.81 (+0.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the...

See More

Key Turning Points

3rd Resistance Point 123.00
2nd Resistance Point 122.06
1st Resistance Point 120.93
Last Price 119.81
1st Support Level 118.86
2nd Support Level 117.92
3rd Support Level 116.79

See More

52-Week High 127.68
Last Price 119.81
Fibonacci 61.8% 109.33
Fibonacci 50% 103.67
Fibonacci 38.2% 98.00
52-Week Low 79.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar